A novel mutation in the AMHR2 gene, resulting in persistent Müllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia

J Pediatr Endocrinol Metab. 2023 Jul 24;36(9):890-894. doi: 10.1515/jpem-2023-0245. Print 2023 Sep 26.

Abstract

Objectives: To highlight important clinical aspects of Persistent Müllerian duct syndrome (PMDS). PMDS belongs to the group of differences of sex development. It is attributed to mutations in genes encoding for the anti-Müllerian hormone or its type II receptor (AMHR2) and inherited via an autosomal recessive transmission.

Case presentation: An 18-day-old male infant with known bilateral cryptorchidism, presented with left-sided obstructed inguinal hernia. The diagnosis of PMDS was considered during inguinal exploration as both testes together with uterus and fallopian tubes were recognized in the hernial sac. Histology confirmed the presence of Müllerian-derived tissues. Genetic testing revealed two different mutations of the AMHR2 gene, both with autosomal recessive transmission: a frequently encountered deletion of 27 pairs bases on exon 10 of this 11 exon gene and a novel deletion of 2 pairs bases on exon 6.

Conclusions: This case is notable being the rarest type of PMDS, that of transverse testicular ectopia and associated with a novel AMHR2 gene mutation.

Keywords: anti-Müllerian hormone (AMH); persistent Müllerian duct syndrome (PMDS); transverse testicular ectopia (TTE).

Publication types

  • Case Reports

MeSH terms

  • Cryptorchidism* / complications
  • Cryptorchidism* / genetics
  • Disorder of Sex Development, 46,XY
  • Exons
  • Female
  • Hernia, Inguinal* / complications
  • Hernia, Inguinal* / genetics
  • Humans
  • Infant, Newborn
  • Male
  • Pelvis

Supplementary concepts

  • Persistent Mullerian duct syndrome